Navigation Links
A New Weapon In The Battle Of The Bra Bulge
Date:11/17/2009

PRINCETON JUNCTION, N.J., Nov. 17 /PRNewswire/ -- It is the bane of many women's existence: fat bulges in the back area around the bra and bra straps, commonly referred to as "bra bulge." Making matters even worse: bra bulge does not respond to diet and exercise like other areas of the body, making women go to great lengths to camouflage or cover them up with loose fitting clothing that is often too big, or body-slimming outfits that temporarily slims them down.

While standard liposuction alone has always been an option for people who want to eliminate bra bulge for good, it is an invasive surgical procedure commonly used on larger areas like the thighs or abdomen that requires general anesthesia and a long healing process. Thankfully, there is a new option for women that gets rid of bra bulge and tightens the skin: AccuSculpt(TM), the most effective body-sculpting tool on the market.

Developed by Lutronic, Inc., a leading developer of high quality, affordable medical and aesthetic laser systems, AccuSculpt is the first in its class of cutting-edge, minimally invasive treatments that targets and eliminates fat from trouble spots such as the mid-back, eradicating bra bulge for good.

"AccuSculpt laser is ideal for small areas of the upper and mid-back. The tiny laser is only six hair fibers in width that emulsifies the fat and tightens the skin at the same time, all under local anesthesia," says Dr. Daniel Man, a plastic surgeon in Boca Raton, Florida. "It is the perfect solution for bra bulge since the tiny incisions are hidden in the bra line."

Its proprietary 1444 wavelength makes AccuSculpt eight times more effective at emulsifying fat than other Laser Assisted Lipolysis (LAL) treatments currently available, providing aesthetic physicians an incredible tool that produces safe, effective, permanent results previously unattainable.

"Having used all modalities of liposuction, including traditiona
'/>"/>

SOURCE Lutronic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hypoglycemia Education - A Vital Weapon in the Battle to Conquer Diabetes
2. Texas State Tests Potential New Cancer-Fighting Weapon
3. New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
4. U.S. Naval Medical Research Center Resubmits IND Application for Proposed Op RESUS Clinical Trial in Trauma Patients in the Battlefield Setting
5. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
6. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
7. Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup
8. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... today that it acquired Bionik Laboratories, Inc., a ... the sale to qualified accredited investors of units consisting ... proceeds of approximately $6.2 million. Shares of the Company,s ... OTC Markets under the symbol "DWTPD" until FINRA,s approval ...
(Date:2/27/2015)... , Feb. 27, 2015  Two ... increasing in applications as their effectiveness is ... Kalorama Information.  Kalorama Information says that while ... the most powerful tool in proteomic biomarker ... MS) through its traditional techniques has struggled ...
(Date:2/26/2015)... 2015 RnRMarketResearch.com adds Corneal ... report to its store. This report p provides ... The report "Corneal Ulcers - Pipeline Review, H2 ... for Corneal Ulcers. Corneal Ulcers are primarily result ... viral infections & fungal infections. The symptoms of ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... phase II/III clinical trial,anticipated later this year, ... Inc. (CTI) announced the publication of preclinical,studies, ... resulted in minimal or no significant cardiotoxicity, ... studies compared the cardiac side effects of ...
... 2007 - New data from an,investigational study ... Annual Scientific Sessions showed that initial,combination therapy ... in markers of beta cell,function in patients ... function determines the ability of the body ...
Cached Medicine Technology:Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31
(Date:3/1/2015)... “ The Barrel Mill ” was featured on NewsWatch ... look at the latest and coolest technology products and services ... a technology expert, conducted the review and shared with viewers ... According to Home Distillation of Alcohol, it's understood that oak ... pretty cool product that’ll help anyone achieve a barrel aged ...
(Date:3/1/2015)... February 28, 2015 CrossFit Attollo is a ... are offering a special discount to new members. Now ... for a three month contract will receive their fourth month ... would cost members $440. The three month contract is ... and then the fourth month comes in at only $55. ...
(Date:2/28/2015)... In recent years Medical Marijuana has continuously ... as a way for them to expand their patient base ... medicine. Since the FDA still lists Cannabis as a Schedule ... licensed physicians that can help guide them when recommending ... in Santa Cruz, CA is a leader in the ...
(Date:2/28/2015)... February 28, 2015 In a recent ... of Game Change Athlete Development Services ... about the benefits of athlete development and player engagement ... the unique challenges that athletes face and how off-field ... success. , Fletcher became involved in athlete development issues ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3
... law suit filed against sunscreen manufacturers in California as they ... on the other hand still recommend the liberal use of ... (SPF) ratings nor the label on the products gives a ... not cause burning but do cause aging of the skin ...
... of marriages. // ,Pathology labs in the city have registered ... season. ,Rajesh Bose (name changed) got an HIV test ... But her parents thought I was a flirt," said Bose. "But when ... ,Not only men but prospective brides too are going in ...
... Roseborough et al., mitochondrial K-ATP channel opener, diazoxide, prevents ... are the common problems that occur during aortic surgery ... in neurological deficits. But the works of Roseborough et ... injuries. , The results of his work ...
... protein present in chronic inflammatory conditions called heat shock ... – which is associated with the immune responses, a ... ,The specific response has earlier been observed in juvenile ... the role of HSP60 in inflammatory myositis. Inflammatory myositis ...
... club, for people living with HIV/Aids, started by Luta Shaba, an ... country. // ,Shaba says she dreams of ... use recommended safe sex methods. She says many of her ... large social stigma attached to HIV/Aids. Her club is a huge ...
... a coordinated action plan to check the deteriorating sexual ... ,The plan by UN agencies, WHO and UN Population ... more than half a million women die during pregnancy ... annually. , ,"There is a really worrying rise ...
Cached Medicine News:Health News:New Way To Combat Spinal Cord Injury during Aortic Surgery 2Health News:Proteins – A New Way to Treat Children's Muscle Diseas 2
The Advia 60 is designed to deliver powerful performance in a small package....
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
... 750 analyzer is equipped with ... random access capabilities. These advancements ... pre-sorting of samples and speed ... system, you can improve overall ...
Creatinine Test Kit (enzymatic, liquid reagents), Wavelength: 550 nm. Linear range: up to 150 mg/dL....
Medicine Products: